How Biotech Labs are Adjusting to the COVID-19 Era

Lily Helfrich

As an industry that relies on having employees in the lab, biotech has been disrupted by COVID-19 and the dramatic and unexpected set of changes it has introduced. For many scientists, working remotely is a brand new concept. And yet, the scientific industry is also being called upon to develop tests, therapies, and vaccines that put this crisis to rest.

To share how biotechs around the world are managing their projects, caring for their people, and supporting the community during coronavirus, we built a guide with best practices and unique ideas from our customers.


Download the Guide

Sign up for the Benchling newsletter

Get our latest insights and announcements every month.